The effects of porcine somatotropin and dietary lysine on growth performance and carcass characteristics of finishing swine fed to 105 or 127 kilograms.

One hundred twenty barrows (initially 59 kg) were used to determine the effects of dietary lysine and porcine somatotropin (pST) on growth performance and carcass characteristics of finishing pigs fed to heavy market weights (127 kg). Pigs were injected daily with either 4 mg of pST or a placebo and fed diets containing either .8, 1.0, 1.2, or 1.4% lysine in a 2 x 4 factorial arrangement. Performance data were collected and evaluated for the weight ranges: 59 to 105, 105 to 127, and 59 to 127 kg. In addition, daily accretion rates of protein (DPA), lipid (DLA), moisture, and ash were determined by slaughtering six randomly selected pigs at the start of the experiment, then one pig per pen when pigs reached mean weights of 105 and 127 kg. Pigs injected with pST had greater (P < .05) ADG than control pigs at all weight ranges. Increased dietary lysine had no effect (P > .20) on ADG during the entire trial (59 to 127 kg). Although control pigs showed no increase in ADG with increasing lysine, ADG of pST-treated pigs tended to increase. This resulted in a pST x lysine interaction (P < .07) for ADG from 59 to 127 kg. Feed consumption decreased (P < .05) in pigs from 59 to 105 kg and 59 to 127 kg with pST treatment and with increasing dietary lysine. Feed conversion (G/F) was improved (P < .01) by pST administration and a tendency for a pST x lysine interaction (P < .12) was observed. At 105 kg, average backfat thickness, kidney fat, longissimus muscle area, and DPA were unaffected by dietary lysine but were improved by pST treatment (P < .01). At a slaughter weight of 127 kg, average backfat thickness decreased and DPA increased (linear, P < .05) with increasing dietary lysine and pST treatment (P < .01). Longissimus muscle area was increased and DLA was decreased (P < .01) by injections of pST but both were unchanged by dietary lysine. These data indicate that growth performance and carcass characteristics at 105 and 127 kg were improved by daily administration of 4 mg of pST. At both slaughter weights, increasing dietary lysine resulted in increased carcass leanness (increased carcass protein and decreased carcass lipid). Although increasing lysine did not improve overall (59 to 127 kg) ADG and feed efficiency, pST-treated pigs showed a greater response to increasing dietary lysine. The data indicate that pST-treated pigs (4 mg/d) require approximately 28 g/d of lysine.

Interrelationships between porcine somatotropin and dietary lysine on growth performance and carcass characteristics of finishing swine.

Seventy-two barrows (initial weight = 57.1 kg) were used to determine the interrelationship between porcine somatotropin (pST) and dietary lysine and their effects on growth performance and carcass characteristics. Pigs were injected daily in the extensor muscle of the neck with either 4 or 8 mg of pST and fed a pelleted corn-soybean meal-sesame meal diet (.8% lysine; 17.8% CP) or diets containing 1.0, 1.2, or 1.4% lysine provided by additions of L-lysine.HCl (2 x 4 factorial arrangement). Control pigs (placebo injection) received the .8% lysine diet. All diets were formulated to contain > or = 200% of current recommendations for other amino acids, vitamins, and minerals. A tendency for a pST x lysine interaction was observed for cumulative ADG (P < .15) and feed conversion (G/F; P < .05). Average daily gain and G/F were improved by increasing dietary lysine level in pigs injected with 4 mg/d of pST; however, pigs injected with 8 mg/d of pST had greater improvements in cumulative ADG and G/F with added lysine. Feed intake was reduced (quadratic, P < .10) as dietary lysine level and pST dosage increased. Increasing pST dosage and dietary lysine increased (linear, P < .05) longissimus muscle area and decreased backfat thickness. Trimmed ham and loin weights were increased (linear, P < .10) by pST dosage. Chemical composition of samples taken from the loin, ham, and belly indicated increased moisture and CP and decreased lipid content as pST dosage and dietary lysine level increased (quadratic, P < .05). Shear force values from loin and semimembranosus increased with increasing lysine level (quadratic, P < .01) and pST dosage (linear, P < .05); however, these differences were not detected by sensory analysis (P > .20). Plasma urea concentrations on d 28 decreased with increasing lysine level (quadratic, P < .05), and plasma lysine concentrations increased (linear, P < .01). Based on the pST x lysine interaction for ADG and G/F, these data suggest that the lysine level needed to maximize growth performance and carcass characteristics may be proportional to the pST dosage provided. Growth and carcass characteristics were maximized by dietary lysine intakes of 27 to 32 and > or = 36 g/d for pigs injected with 4 and 8 of mg/d of pST, respectively.

Porcine somatotropin and dietary lysine influence bone mineralization and mechanical properties of bones in finishing swine.

The femur, a rib, and a third metacarpal were collected from 108 barrows (initial weight = 57 kg) and analyzed to determine the effects of porcine somatotropin (pST) and dietary lysine on bone mineralization and mechanical properties. In Exp. 1, pigs were injected daily with 4 mg of pST and fed diets containing 1.0% Ca and .9% P and either .6, .8, 1.0, 1.2, or 1.4% lysine. Control pigs (placebo injection) received the .6% lysine diet. Bone wall thickness (BWT) of the femur increased (linear, P < .05) but ash content decreased (linear, P < .10) as dietary lysine level increased. Stress and ash content of the rib also decreased (linear, P < .05) with increasing dietary lysine level. In Exp. 2, pigs were injected with either 4 or 8 mg/d of pST and fed diets containing 1.1% Ca and 1.0% P and either .8, 1.0, 1.2, or 1.4% lysine. Control pigs received the .8% lysine diet. Increasing pST dosage increased BWT of the femur (linear, P < .10) but decreased ash content (linear, P < .10). In the rib, increasing pST dosage reduced stress, modulus of elasticity (linear, P < .10), and ash content (linear, P < .01). Increasing lysine level resulted in increased BWT of the femur and decreased ash content of rib, femur, and metacarpal (linear, P < .10). These data indicate that pST administration in conjunction with increasing lysine levels decreases bone ash content but increases BWT of finishing pigs.

Recombinant porcine somatotropin for sows during late gestation and throughout lactation.

Two experiments were conducted to evaluate whether administration of recombinant porcine somatotropin (pST) to sows (Hampshire-Yorkshire) enhanced lactational performance. In Exp. 1, sows (n = 84) were fed a corn-soybean meal diet (17.8% CP), or a similar diet with 8% added fat, from d 108 of gestation to d 28 of lactation. Half of the sows fed each diet were injected with 6 mg/d of pST from d 108 of gestation to d 24 of lactation. Diets were fed at 2.27 kg/d from d 108 of gestation until farrowing and then were self-fed during lactation. By d 3 of lactation, litter size was standardized at 8 to 10 pigs per litter. Treating sows with pST resulted in a 10-fold increase (P less than .001) in serum somatotropin at 4 h postinjection. Serum glucose was increased (P less than .01) and serum triglycerides, creatinine, and urea N were decreased (P less than .01) by pST. During the summer, apparent heat stress occurred in pST-treated sows, resulting in 14 deaths. Most (10) of the deaths occurred just before, during, or shortly after farrowing. Fewer (P less than .08) deaths occurred when pST-treated sows were fed the diet with added fat. Sows treated with pST consumed less feed (P less than .10) and lost more backfat (P less than .10) during lactation than controls. Increasing the dietary fat did not prevent these changes. Weaning weights of pigs and milk yield of sows (estimated by deuterium oxide dilution) were not affected by pST treatment. In Exp. 2, sows (n = 42) were injected weekly with 0 or 70 mg of pST on d 3, 10, 17, and 24 of lactation. Litters were standardized by d 3 at 8 to 10 pigs, and sows were fed the same control (low fat) diet as in Exp. 1. Sows treated with pST consumed less feed and lost more weight and backfat during lactation than untreated sows. Litter size, average pig weaning weights, and milk yield were not influenced by pST treatment. These data indicate that a 6-mg daily injection of pST from 6 d prepartum to d 24 of lactation or a 70-mg weekly injection of pST from 3 d postpartum to d 24 of lactation does not increase milk production in lactating sows.

Exogenous human growth hormone-releasing factor and ovine somatotropin improve growth performance and composition of gain in lambs.

The objectives of this study were 1) to compare intermittent subcutaneous administration of human growth hormone-releasing factor (hGRF) at two doses with a similar regimen of ovine somatotropin (oST) for effects on growth and composition of gain in growing lambs and 2) to determine whether increasing the dietary amino acid availability enhances response to oST or hGRF. Eighty crossbred ewe and wether lambs (25.5 kg live weight) were assigned randomly in pairs to receive four daily injections of excipient, 40 micrograms oST/kg BW, 5 micrograms hGRF/kg BW or 10 micrograms hGRF/kg BW for 42 (n = 80) or 56 (n = 40) d. Doses were adjusted weekly for BW. Mean plasma oST concentrations increased from 2.03 ng/ml prior to treatment to 20.64, 4.80 and 5.45 ng/ml with oST, 5 and 10 micrograms/kg hGRF doses, respectively. Lambs did not become refractory to hGRF. Cumulative gain increased approximately 18% with 7 wk of treatment with oST and the low dose of hGRF (both P less than .01), and feed efficiency improved 21% with oST and 18% with both doses of hGRF (both P less than .05). Carcass lipid accretion rate decreased 22% to 30% (P less than .001), and carcass protein accretion rate increased 30% to 36% (P less than .001) with hGRF and oST treatment, respectively. Addition of fishmeal to the diet at 4% to replace an equal amount of soy protein improved gain 8.5%; it improved efficiency 14.2% (P less than .05) across all treatments, and it significantly enhanced the effects of oST on feed efficiency (interaction P less than .12) and hind leg muscle weights.

The effect of human growth hormone-releasing factor or porcine somatotropin on serum hormones and metabolites, growth performance and carcass traits in swine.

Forty barrows (77.9 +/- 5.5 kg BW) were allotted to one of five treatment groups to examine the effects of various doses of human growth hormone-releasing factor (1-44)NH2 (hGRF) or porcine somatotropin (pST) administered twice daily on serum hormones and metabolites, performance and carcass traits. Barrows were injected s.c. with either a placebo, 10 micrograms hGRF.kg BW-1.12 h-1, 20 micrograms hGRF.kg BW-1.12 h-1, 20 micrograms pST.kg BW-1.12 h-1 or 40 micrograms pST.kg BW-1.12 h-1 for a 36-d growth trial. Blood samples were collected from 13 barrows at intervals for 360 min after injection on d 21. Compared with the placebo, 10 micrograms hGRF.kg-1.12 h-1 increased (P less than .01) serum pST and insulin and decreased (P less than .001) urea N. Injecting 20 micrograms hGRF/kg.12 h-1 elevated (P less than .001) serum pST, insulin and insulin-like growth factor-I (IGF-I) but lowered (P less than .001) urea N. Exogenous pST increased (P less than .001) serum pST, insulin, IGF-I and glucose but decreased (P less than .001) urea N. Growth rate tended to increase, and feed intake and feed/gain decreased, in a dose-related manner in response to hGRF. Also, pigs receiving 10 or 20 micrograms hGRF.kg-1.12 h-1 had reduced (P less than .1) backfat and increased (P less than .1) loineye area and percentage lean in the ham compared with pigs receiving the placebo. At equal doses, pST elicited more dramatic improvements in performance and carcass criteria than did hGRF.(ABSTRACT TRUNCATED AT 250 WORDS)

The effects of porcine somatotropin and dietary lysine on growth performance and carcass characteristics of finishing swine.

Seventy-two finishing pigs (initial weight = 57.6 kg) were utilized to determine the effects of porcine somatotropin (pST) and dietary lysine level on growth performance and carcass characteristics. Pigs were injected daily with 4 mg pST in the extensor muscle of the neck and fed either a pelleted corn-sesame meal diet (.6% lysine, 17.8% CP) or diets containing .8, 1.0, 1.2 or 1.4% lysine provided by additions of L-lysine.HCl. All diets were formulated to contain at least twice the required amounts of other amino acids. Control pigs received a placebo injection and the .6%-lysine diet. Increasing levels of dietary lysine resulted in increased ADG and improved feed conversion (quadratic, P less than .01) for pST-treated pigs. The calculated daily lysine intake was 16.6, 13.6, 19.6, 25.1, 29.6 and 33.6 g for the control and pST-treated pigs fed .6, .8, 1.0, 1.2 and 1.4% lysine, respectively, over the entire experiment. Breakpoint analysis indicated that cumulative ADG and feed conversion were optimized at 1.19 and 1.22% lysine, respectively. Longissimus muscle area and trimmed ham and loin weights increased as dietary lysine was increased among pST-treated pigs (quadratic, P less than .01). Breakpoint analysis indicated that 1.11% lysine maximized longissimus muscle area, whereas trimmed ham and loin weights were maximized at .91 and .98% lysine, respectively. Adjusted backfat thickness was not affected by dietary lysine, but pST-treated pigs had less backfat (P less than .05) than control pigs did. Percentage moisture of the longissimus muscle increased (linear, P less than .05), as did percentage CP (quadratic, P less than .05), whereas fat content decreased (linear, P less than .05) as lysine level increased. Similar trends in composition were observed for muscles of the ham (semimembranosus, semitendinosus, and biceps femoris). Shear-force values from the longissimus and semimembranosus were lowest for control pigs, but they increased as dietary lysine level increased among pST-treated pigs. Sensory panel evaluations indicated that juiciness and tenderness decreased (linear, P less than .05) as dietary lysine level increased. Plasma urea concentrations decreased linearly (P less than .01) on d 28 as lysine level increased, whereas plasma lysine and insulin were increased (quadratic, P less than .01). Plasma glucose and free fatty acid concentrations on d 28 tended to increase (quadratic, P less than .10) with increasing dietary lysine level.(ABSTRACT TRUNCATED AT 400 WORDS)

Influence of lysocellin and monensin on mineral metabolism of steers fed forage-based diets.

Studies were conducted to determine the effects of lysocellin and monensin on mineral metabolism of steers fed forage-based diets. In each study treatments consisted of 1) control, 2) 100 mg lysocellin/d, 3) 200 mg lysocellin/d and 4) 200 mg monensin/d. Twenty-four growing Hereford steers were used in each of two experiments to evaluate the effects of ionophore feeding on plasma and ruminal soluble mineral concentrations. Steers were fed individually greenchop (tall fescue and bermudagrass) ad libitum and .91 kg/d of a corn-trace mineral salt-ionophore supplement. Plasma and ruminal fluid samples were obtained on d 28 and 84 in both studies. Ruminal concentrations of soluble phosphorus (P) and iron (Fe) were higher (P less than .05), whereas soluble manganese (Mn) was lower (P less than .01), in steers fed lysocellin than in controls. Steers fed lysocellin had higher (P less than .05) plasma magnesium (Mg) concentrations than control steers. Plasma and ruminal soluble mineral concentrations generally were similar for the monensin and 200 mg lysocellin treatments. Two additional studies were conducted to determine the effects of lysocellin and monensin on macromineral apparent absorption and retention in steers fed tall fescue greenchop. Steers were adjusted to their diets for 28 d and then placed in metabolism crates for a 6-d acclimation followed by a 5-d collection of urine and feces. Percent apparent absorption of calcium (Ca), potassium (K), Mg and P was higher (P less than .05), whereas sodium (Na) absorption was lower (P less than .05), in steers fed lysocellin than in controls. Mineral absorption was similar in steers fed 200 mg lysocellin or monensin. Calcium (P less than .05) and K (P less than .10) retention (percent of intake) was increased by ionophore feeding. Results indicate that lysocellin and monensin alter apparent absorption and retention of certain minerals in steers fed forage-based diets.

Effects of Rumen-Mate on lactational performance of Holsteins fed a high grain diet.

Three Latin-square trials were conducted to determine the effects of supplementing Rumen-Mate, a commercial buffer containing KCl, NaCl, and Mg and Na carbonates, on lactation performance of Holsteins. Cows were fed a basal ration of 40% corn silage and 60% concentrate in Trials 1 and 2, and 40% corn silage, 55% concentrate, and 5% alfalfa hay in Trial 3 (DM basis). In Trial 1, treatments were: basal diet, or basal diet supplemented with either 1% NaHCO3, or 1, 3, or 4.4% Rumen-Mate. Increasing dietary Rumen-Mate resulted in a linear increase in milk fat production and concentration with no difference between 1% Rumen-Mate and 1% bicarbonate. There was a significant linear decrease in milk protein concentration, but not production, with increasing concentrations of Rumen-Mate. In Trial 2 treatments were: basal diet, or basal diet supplemented with either .8% NaHCO3, 2.6% Rumen-Mate, .5% MgO, .8% NaHCO3 plus .5% MgO, or 1.8% Rumen-Mate plus .8% NaHCO3. Organic matter and CP intakes and milk protein yield and concentration were decreased by Rumen-Mate with a nonsignificant increase in milk fat concentration. Data from Trials 1 and 2 were combined with data from Trial 3, which compared basal diet, 1% bicarbonate, and 3% Rumen-Mate. The combined data showed a larger increase over basal diet in milk fat yield and concentration for 2.6 to 3% Rumen-Mate vs. .8 to 1% bicarbonate. Rumen-Mate did not decrease DM intake or protein yield relative to basal diet but did decrease protein yield 34 g/d compared with that of bicarbonate.

Effect of dietary potassium chloride on feeder pig performance, market shrink, carcass traits and selected blood parameters.

A total of 288 commingled crossbred feeder pigs were purchased and transported 1,050 km in two trials to investigate the effect of added dietary potassium chloride in receiving and finishing diets on feeder pig shrink recovery, performance and pre-slaughter shrink. Diets containing 0, .48%, .96% or 1.44% added potassium chloride were fed for 2 wk post-arrival and again from 12 wk post- arrival until slaughter. There was no effect (P greater than .1) on gain (22.9 kg pay weight) or feed conversion or on plasma or red blood cell potassium for the 2-wk post-arrival period due to the inclusion of potassium chloride in the 2-wk receiving diet. Also, there was no effect (P greater than .1) of potassium chloride in diets from 12 wk post-arrival until slaughter on gain, feed conversion, market shrink, carcass dressing percentage and plasma or red blood cell potassium concentration at slaughter. These results suggest that corn-soybean meal-based diets contain sufficient potassium for pigs following a period of stress associated with marketing and transport.

Effects of a new multielement buffer on production, ruminal environment, and blood minerals of lactating dairy cows.

Twelve multiparous Holstein cows were used to evaluate the capacity of a multielement compound consisting mainly of northupite and sylvite to alleviate low milk fat percent. Possible mechanisms of action were assessed. Cows were arranged in a 4 X 4 Latin square design replicated three times. Basal diet was 55% concentrate:45% forage fed ad libitum. Dietary treatments were control, NaHCO3 at 1% of diet DM, and multielement buffer at 1 and 3% of diet DM. Feed intake and milk production were similar for all treatments. Milk fat percentages for the four treatments were 2.97, 3.21, 3.43, and 3.67%, respectively. A shift toward a higher molar percent of ruminal acetate and a lower molar percent of valerate appeared to coincide with changes in milk fat percentage. Milk protein percentage also was increased by supplemental multielement buffer. Ruminal fluid acidity was reduced by NaHCO3 and multielement buffer. Extent of in situ digestion of forage DM and cellulose was improved when cows consumed a buffering agent. Rate of corn silage digestion tended toward improvement. As mineral buffer was consumed, concentrations of Mg and K increased in ruminal fluid and blood. As dietary Na intake increased, ruminal and plasma Cl concentrations were depressed and plasma S and Ca were elevated.

Plasma somatotropin response to exogenous growth hormone releasing factor in lambs.

Two experiments were performed to examine the ability of human pancreatic growth hormone releasing factor (hGRF) administration to stimulate endogenous growth hormone (GH) secretion in lambs. Each study utilized eight Dorset wether lambs in replicated 4 X 4 Latin square experiments. Growth hormone response (integrated area under the curve for 150 min post-injection) for 0, 1, 5 and 10 micrograms hGRF/kg body weight averaged 13, 23, 92 and 134 units, respectively. While the 1-microgram hGRF dose was not different (P greater than .05) than the response to saline injection, there was an increased (P less than .01) GH response to 5 or 10 micrograms hGRF. Overall the GH response increased in a log dose-response fashion. There was distinct variation between lambs in their response to hGRF. Study II examined the optimal method to administer 40 micrograms hGRF/kg body weight to maximize GH concentration over 24 h. Continuous infusion (CI) was compared with eight (8X), four (4X), or two (2X) injections/d. Hourly blood samples were obtained from all lambs. Growth hormone response (area under the curve for 24 h) was 162, 305, 306 and 220 units for CI, 8X, 4X and 2X, respectively. Growth hormone response to CI was inferior to discrete injections, and the GH response to 4X or 8X was superior to 2X/d. Results demonstrate that, in spite of lamb-to-lamb variation, one can utilize exogenous hGRF to enhance GH secretion in lambs. Thus, the ability of exogenous hGRF to enhance growth performance merits further study.

Effects of iron status and soy protein on iron absorption by rats.

The effects of iron nutrition and soy protein on iron absorption by rats was studied. Rats were fed semipurified diets containing either 0, 5, or 20 micrograms of added iron per gram of diet to obtain groups with different iron status. After 3 weeks the rats had mean hemoglobin concentrations of 7.0, 10.7 and 13.2 g/dl, respectively. As the rats became more anemic, percent iron absorption from casein and soy protein diets increased. The relative availability of iron from soy compared with casein-based diets was 70 to 90%. Iron status did not affect the relative iron availability among treatments. The rat trials did not indicate any significant differences between iron absorption from meals containing soy flour (SF), soy protein concentrate (SC) or soy protein isolate (SI) regardless of the iron status of the rat. These studies do not support the hypothesis that the subject's iron status will affect the relative availability of iron from foods. Recent human iron absorption studies suggest that relative iron availability from meals containing soy proteins is lower than expected based on rat studies. Furthermore, differences in iron availability between soy flour and soy isolate observed in human studies are not apparent in these rat studies.

In vitro estimation of iron availability in meals containing soy products.

Effects on relative nonheme iron availability of soy protein products incorporated into meals were evaluated. An in vitro method was used to estimate nonheme iron availability. Incorporation of soy isolate into a semisynthetic meal reduced estimated iron availability (dialyzable iron) compared to an egg white control, but this effect was reversed by baking the soy isolate. Ascorbic acid was not as effective in increasing estimated iron availability in soy-containing meals as in an egg white control meal. When 34 individual soy products were substituted for egg white in semisynthetic meal, iron availability range from 3.23 to 0.00% dialyzable iron. Iron availability appears to be inversely related to the protein content of the soy products. Soy isolates, as a group, had lower relative iron availability than the group of soy flours evaluated. The amount of soy product protein incorporated into a standard meal was negatively correlated with relative iron availability. The majority of meals containing soy products had lower estimated iron availabilities than meals that did not contain soy.

Biological effects of substituting enriched 54Fe for natural iron in rats.

The effect of feeding an enriched stable isotope of iron, 54Fe, to rats was examined. Weanling rats were fed semisynthetic diets in which 54Fe was substituted for all added natural iron for a period of 21 days. Growth; feed conversion; total liver, spleen, and femur iron; and hemoglobin concentrations; hematocrit; RBC and WBC volume; FEP concentration; kidney and heart aconitase activities; erythrocyte and liver catalase activities; liver microsomal oxidase activity; and pathological lesions did not differ between control and 54Fe enriched animals. Based on the biochemical and histological parameters examined in the study an isotope effect of 54Fe was not observed.

A comparison of in vivo and in vitro methods for determining availability of iron from meals.

A comparison is made between in vitro and human and rat in vivo methods for estimating food iron availability. Complex meals formulated to replicate meals used by Cook and Monsen (Am J Clin Nutr 1976;29:859) in human iron availability trials were used in the comparison. The meals were prepared by substituting pork, fish, cheese, egg, liver, or chicken for beef in two basic test meals and were evaluated for iron availability using in vitro and rat in vivo methods. When the criterion for comparison was the ability to show statistically significant differences between iron availability in the various meals, there was substantial agreement between the in vitro and human in vivo methods. There was less agreement between the human in vivo and the rat in vivo and between the in vivo and the rat in vivo and between the in vitro and the rat in vivo methods. Correlation analysis indicated significant agreement between in vitro and human in vivo methods. Correlation between the rat in vivo and human in vivo methods were also significant but correlations between the in vitro and rat in vivo methods were less significant and, in some cases, not significant. The comparison supports the contention that the in vitro method allows a rapid, inexpensive, and accurate estimation of nonheme iron availability in complex meals.

An in vitro method for estimation of iron availability from meals.

An in vitro method for estimating food iron availability is described. The method involves simulated gastrointestinal digestion followed by measurement of soluble, low molecular weight iron. Mixtures of foods (meals) were homogenized and exposed to pepsin at pH 2. Dialysis was used to adjust the pH to intestinal levels and digestion was continued after the addition of pancreatin and bile salts. Iron from the digestion mixture which diffused across a 6 to 8000 molecular weight cutoff semipermeable membrane was used as an indicator of available iron. Results were similar when intrinsic food iron or added extrinsic radioiron was measured. Availability estimates were made on meals formulated to contain known iron availability enhancing and inhibiting factors. Relative availabilities determined for a series of meals containing ascorbic acid, eggs, orange juice, tea, coffee, cola, or whole wheat bread show that the method accurately reflects actual food iron availability.